Karolina Andersson Sundell
Karolina Andersson Sundell
Associate Professor, Univeristy of Gothenburg
Verified email at gu.se
Title
Cited by
Cited by
Year
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance
B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ...
Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009
1572009
The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review
B Wettermark, H Zoega, K Furu, M Korhonen, J Hallas, M Nørgaard, ...
Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013
1442013
What are the obstacles to generic substitution? An assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in Sweden
K Andersson, C Sonesson, M Petzold, A Carlsten, K Lönnroth
Pharmacoepidemiology and drug safety 14 (5), 341-348, 2005
1142005
Impact of a generic substitution reform on patients’ and society's expenditure for pharmaceuticals
K Andersson, G Bergström, MG Petzold, A Carlsten
Health Policy 81 (2-3), 376-384, 2007
1102007
Recent national and regional drug reforms in Sweden
B Wettermark, B Godman, K Andersson, LL Gustafsson, A Haycox, ...
Pharmacoeconomics 26 (7), 537-550, 2008
1082008
Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures?: Interrupted time series analysis of cost, volume and cost per volume trends in Sweden …
K Andersson, MG Petzold, C Sonesson, K Lönnroth, A Carlsten
Health policy 79 (2-3), 231-243, 2006
842006
Prevalence, nature and potential preventability of adverse drug events–a population‐based medical record study of 4970 adults
KM Hakkarainen, H Gyllensten, AK Jönsson, K Andersson Sundell, ...
British journal of clinical pharmacology 78 (1), 170-183, 2014
682014
Methods for assessing the preventability of adverse drug events
KM Hakkarainen, KA Sundell, M Petzold, S Hägg
Drug safety 35 (2), 105-126, 2012
662012
A comparative analysis of remuneration models for pharmaceutical professional services
C Bernsten, K Andersson, Y Gariepy, S Simoens
Health policy 95 (1), 1-9, 2010
642010
Prevalence and perceived preventability of self-reported adverse drug events–a population-based survey of 7099 adults
KM Hakkarainen, KA Sundell, M Petzold, S Hägg
PLoS One 8 (9), e73166, 2013
562013
Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey
H Gyllensten, C Rehnberg, AK Jönsson, M Petzold, A Carlsten, ...
BMJ open 3 (6), 2013
542013
Adherence to antihypertensive therapy and elevated blood pressure: should we consider the use of multiple medications?
K Hedna, KM Hakkarainen, H Gyllensten, AK Jönsson, KA Sundell, ...
PLoS One 10 (9), e0137451, 2015
512015
Beliefs about medicines are strongly associated with medicine‐use patterns among the general population
K Andersson Sundell, AK Jönsson
International journal of clinical practice 70 (3), 277-285, 2016
492016
Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years
KA Andersson, MG Petzold, P Allebeck, A Carlsten
BMC health services research 8 (1), 1-9, 2008
492008
Socioeconomic determinants of psychotropic drug utilisation among elderly: a national population-based cross-sectional study
E Lesén, K Andersson, M Petzold, A Carlsten
BMC Public Health 10 (1), 1-9, 2010
412010
Beliefs about medicines among Swedish pharmacy employees
TM Jörgensen, KA Andersson, ACM Mårdby
Pharmacy World and Science 28 (4), 233-238, 2006
412006
Glucose‐lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register
N Ekström, M Miftaraj, AM Svensson, K Andersson Sundell, J Cederholm, ...
Diabetes, Obesity and Metabolism 14 (8), 717-726, 2012
372012
A comparison of two methods for estimating refill adherence to statins in Sweden: the RARE project
E Lesén, TZ Sandström, A Carlsten, AK Jönsson, AC Mårdby, KA Sundell
Pharmacoepidemiology and drug safety 20 (10), 1073-1079, 2011
372011
Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus—an observational study from the Swedish National Diabetes Register
B Eliasson, AM Svensson, M Miftaraj, JM Jonasson, K Eeg-Olofsson, ...
PloS one 6 (4), e18744, 2011
362011
To what extent does the indicator “concurrent use of three or more psychotropic drugs” capture use of potentially inappropriate psychotropics among the elderly?
E Lesén, M Petzold, K Andersson, A Carlsten
European journal of clinical pharmacology 65 (6), 635-642, 2009
292009
The system can't perform the operation now. Try again later.
Articles 1–20